![Analysis of the Abuse and Diversion of the Buprenorphine Transdermal Delivery System - ScienceDirect Analysis of the Abuse and Diversion of the Buprenorphine Transdermal Delivery System - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S152659001600568X-gr2.jpg)
Analysis of the Abuse and Diversion of the Buprenorphine Transdermal Delivery System - ScienceDirect
Title: Analysis of abuse of buprenorphine transdermal delivery system ( Butrans®) using data from the RADARS® System Poison Cen
Purdue Pharma L.P. Receives FDA Approval for 7.5 mcg/hour Dosage Strength of Butrans® (Buprenorphine) Transdermal System CIII
![These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-26.jpg&id=725911)